Literature DB >> 23075672

Ultrasound imaging for the rheumatologist XLI. Sonographic assessment of the hip in OA patients.

Annamaria Iagnocco1, Emilio Filippucci, Lucrezia Riente, Gary Meenagh, Andrea Delle Sedie, Garifallia Sakellariu, Fulvia Ceccarelli, Carlomaurizio Montecucco, Stefano Bombardieri, Walter Grassi, Guido Valesini.   

Abstract

OBJECTIVES: To investigate the prevalence of ultrasound (US) detectable abnormalities in the hip joints of patients with osteoarthritis (OA) and correlate them with clinical findings and measures of disease severity.
METHODS: Consecutive patients with hip OA were investigated by clinical and US examinations. Bilateral US of the hip joints was performed by using a Logiq9 machine, equipped with a multi-frequency linear probe, operating at 9 MHz; in addition, power Doppler (PD) was applied (frequency 7.5 MHz; PRF 750 Hz). Clinical evaluation included the registration of demographic data, disease duration, current and previous joint pain and Lequesne index. US study included the assessment of both inflammatory and structural abnormalities at the level of hip joint (joint effusion, synovial hypertrophy, local pathologic vascularisation at PD, osteophytes) and periarticular soft tissues (iliopsoas bursitis, trochanteric bursitis, iliopsoas tendinopathy, gluteus medius tendinopathy and gluteus minimus tendinopathy).
RESULTS: One hundred and fifty hips of 75 patients were studied. Clinical examination demonstrated the presence of current hip pain in 80% of patients and previous hip pain in 85.7% of cases. The mean Lequesne Index was 11.9±4.9. US detected effusion in 50% of the joints, synovial hypertrophy in 41.3%, PD signal in 0.7%, osteophytes in 77.3%; at periarticular level, trochanteric bursitis was found in 24.7% of patients, gluteus tendinopathy in 22.7%, iliopsoas tendinopathy in 7.3% and finally iliopsoas bursitis in 1.3%. The presence of current and previous hip pain significantly correlated with the presence of effusion (p=0.01); age and disease duration significantly correlated with the presence of osteophytes (p=0.01). Various US-detected abnormalities were found also in asymptomatic patients. Statistically significant differences between the 2 subgroups of symptomatic and asymptomatic patients were registered for effusion (p=0.003).
CONCLUSIONS: In hip OA, US is a useful imaging tool for analysing both inflammatory and structural damage lesions as well as for differentiating the involvement of joint structures and periarticular soft tissues. In addition, US was able to detect a wide set of abnormalities even in asymptomatic patients, confirming that it is more sensitive than clinical examination in detecting musculoskeletal involvement.

Entities:  

Mesh:

Year:  2012        PMID: 23075672

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  North American musculoskeletal ultrasound scanning protocol of the hip, knee, ankle, and foot: update of a Delphi consensus study.

Authors:  Janeth Yinh; Karina D Torralba; Kristal S Choi; Robert M Fairchild; Amy Cannella; Lorena Salto; Eugene Y Kissin; Ralf Thiele; Edward J Oberle; Bethany Marston; Midori Jane Nishio
Journal:  Clin Rheumatol       Date:  2021-04-05       Impact factor: 2.980

Review 2.  Functional imaging in OA: role of imaging in the evaluation of tissue biomechanics.

Authors:  C P Neu
Journal:  Osteoarthritis Cartilage       Date:  2014-10       Impact factor: 6.576

Review 3.  Does low back pain or leg pain in gluteus medius syndrome contribute to lumbar degenerative disease and hip osteoarthritis and vice versa? A literature review.

Authors:  Masahiro Kameda; Hideyuki Tanimae; Akinori Kihara; Fujio Matsumoto
Journal:  J Phys Ther Sci       Date:  2020-02-14

4.  Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review.

Authors:  Sarah Louise Mackie; Gouri Koduri; Catherine L Hill; Richard J Wakefield; Andrew Hutchings; Clement Loy; Bhaskar Dasgupta; Jeremy C Wyatt
Journal:  RMD Open       Date:  2015-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.